Novo Nordisk is rebranding to 'Novo' and implementing corporate culture changes as it competes for obesity drug market share against rival Eli Lilly. The Danish drugmaker, facing investor pressure and a 15% stock decline this year, will detail its strategy at a September Capital Markets Day event. Despite successful Wegovy oral launch, Novo holds 38.8% obesity market share compared to Lilly's 60.9%.
TrendForce predicts Apple's iPhone Duo will capture 24.8% of the foldable smartphone market in 2026 with 5 million unit shipments, offsetting a broader 20% decline in the segment. Samsung is expected to lead with 35.1% share, while Huawei matches Apple's volume. Apple's design prioritizes thinness by omitting periscope telephoto and using side-mounted Touch ID instead of Face ID.
A detailed analysis of NYC airport rideshare data from 2019–2026 covering 122.8 million trips shows that rider fares rose 52.1% while driver payouts increased only 34.3%, with significant differences between airports and platforms. The project uses a marimo notebook to process TLC's publicly available trip records and reveals that pay differences alone don't explain market share shifts between Uber and Lyft.